LAVYQAGA-Arg(13C6,15N4) (TFA)

LAVYQAGA-Arg(13C6,15N4) (TFA)

• UNSPSC Description: LAVYQAGA-Arg(13C6, 15N4) TFA is a peptide containing 13C6 and 15N4 labeled Arg[1].
• Target Antigen: Isotope-Labeled Compounds
• Type: Isotope-Labeled Compounds
• Related Pathways: Others
• Field of Research: Others
• Assay Protocol: https://www.medchemexpress.com/lavyqaga-arg-13c6-15n4-tfa.html
• Smiles: O=C(N[C@@H](C)C(N[C@@H](C(C)C)C(N[C@@H](CC1=CC=C(C=C1)O)C(N[C@@H](CCC(N)=O)C(N[C@@H](C)C(NCC(N[C@@H](C)C([15NH][13C@@H]([13CH2][13CH2][13CH2][15NH][13C]([15NH2])=[15NH])[13C](O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](CC(C)C)N.O=C(O)C(F)(F)F.[x]
• Molecular Weight: 958.01 (free base)
• References & Citations: [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported